You have 9 free searches left this month | to do more
Showing 1 - 25 of
746 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
U
Recruiting
  • High Grade Myelodysplastic Syndromes
  • Aurora, Colorado
    Universtiy of Colorado Denver
2021-10-19
Oct 19, 2021
N
Active, not recruiting
  • Recurrent Acute Myeloid Leukemia
  • Refractory Acute Myeloid Leukemia
  • Los Angeles, California
  • +3 more
2022-03-25
Mar 25, 2022
A
Recruiting
  • Recurrent IDH1/2 Mutated Glioma
  • Azacitidine
  • Paris, France
    Pitie Salpetriere Hospital
2022-03-28
Mar 28, 2022
W
Active, not recruiting
  • Myelodysplastic Syndromes
  • Saint Louis, Missouri
    Washington University School of Medicine
2022-03-23
Mar 23, 2022
H
Recruiting
  • Myeloid Malignancy
  • azacitidine
  • Detroit, Michigan
    Henry ford hospital
2021-12-23
Dec 23, 2021
U
Recruiting
  • Acute Myeloid Leukemia
  • Aurora, Colorado
    Universtiy of Colorado Hospital
2022-02-15
Feb 15, 2022
M
Active, not recruiting
  • Large B-Cell Diffuse Lymphoma
  • Charleston, South Carolina
    Medical University of South Carolina
2022-03-31
Mar 31, 2022
F
Withdrawn
  • Myelodysplastic Syndrome (MDS)
  • (no location specified)
2021-07-20
Jul 20, 2021
G
Recruiting
  • Acute Myeloid Leukemia
  • NanJing, China
    Department of Hematology, Zhongda Hospital, Medical School of So
2022-03-22
Mar 22, 2022
A
Not yet recruiting
  • Higher Risk Myelodysplastic Syndrome
  • Chronic Myelomonocytic Leukemia
  • AMG 176
  • Azacitidine
  • (no location specified)
2022-01-13
Jan 13, 2022
P
Not yet recruiting
  • T-cell Lymphoma
  • Tucidinostat, Azacitidine combined with CHOP
  • (no location specified)
2021-10-09
Oct 9, 2021
U
Active, not recruiting
  • Acute Myeloid Leukemia
  • Azacitidine and Venetoclax
  • Aurora, Colorado
    University of Colorado Denver
2021-10-12
Oct 12, 2021
U
Not yet recruiting
  • Myeloproliferative Neoplasm
  • BCR-ABL Negative
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
2021-09-29
Sep 29, 2021
I
Not yet recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • (no location specified)
2021-11-21
Nov 21, 2021
S
Not yet recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Canton, Ohio
    Gabrail Cancer Center
2022-03-17
Mar 17, 2022
T
Recruiting
  • Relapsed/Refractory Peripheral T-cell Lymphoma
  • Anti-PD-1 monoclonal antibody
  • +2 more
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
2021-12-21
Dec 21, 2021
U
Recruiting
  • Breast Cancer Female
  • Breast Cancer Invasive
  • Azacitidine
  • Chicago, Illinois
  • +1 more
2022-01-24
Jan 24, 2022
P
Not yet recruiting
  • Acute Myeloid Leukemia, Adult
  • ADI-PEG 20
  • Houston, Texas
    MD Anderson Cancer Center
2021-08-11
Aug 11, 2021
R
Active, not recruiting
  • Pancreas Cancer
  • New York, New York
    Columbia University Irving Medical Center
2021-10-20
Oct 20, 2021
T
Not yet recruiting
  • Leukemia, Myeloid, Acute
  • +2 more
  • venetoclax combining chidamide and azacitidine (VCA)
  • (no location specified)
2022-03-23
Mar 23, 2022
M
Active, not recruiting
  • High Risk Myelodysplastic Syndrome
  • +2 more
  • Azacitidine
  • Pembrolizumab
  • Houston, Texas
    M D Anderson Cancer Center
2021-10-06
Oct 6, 2021
T
Recruiting
  • Patients With Recurrent Acute Myelogenous Leukemia After Transplantation
  • CD47 monoclonal antibody
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University, Jiangsu Ins
2022-03-03
Mar 3, 2022
M
Recruiting
  • Acute Myeloid Leukemia
  • Duarte, California
  • +2 more
2022-01-21
Jan 21, 2022